{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:40:53Z","timestamp":1791924053185,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05641-8","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:37:37Z","timestamp":1784705857000},"page":"3999-4013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The METTL3\/TRIM37 axis contributes to the progression of non-alcoholic fatty liver disease by promoting CAV1 degradation"],"prefix":"10.1007","volume":"481","author":[{"given":"Lingyun","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"5641_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","volume":"29","author":"SK Han","year":"2023","unstructured":"Han SK, Baik SK, Kim MY (2023) Non-alcoholic fatty liver disease: Definition and subtypes. Clin Mol Hepatol 29:S5\u2013S16","journal-title":"Clin Mol Hepatol"},{"key":"5641_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE et al (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7:851\u2013861","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5641_CR3","doi-asserted-by":"publisher","first-page":"e70118","DOI":"10.1002\/dmrr.70118","volume":"42","author":"J Ren","year":"2026","unstructured":"Ren J, Jiang T, Wei X, Bian T, Xu M, Zhao Y et al (2026) Unravelling the Mechanisms of Tea Against NAFLD: An Integration of Bibliometrics, Network Pharmacology, and the Gut-Liver Axis. Diabetes Metab Res Rev 42:e70118","journal-title":"Diabetes Metab Res Rev"},{"key":"5641_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","volume":"292","author":"R Paternostro","year":"2022","unstructured":"Paternostro R, Trauner M (2022) Current treatment of non-alcoholic fatty liver disease. J Intern Med 292:190\u2013204","journal-title":"J Intern Med"},{"key":"5641_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","volume":"26","author":"S Tanwar","year":"2020","unstructured":"Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM (2020) Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol 26:109\u2013133","journal-title":"World J Gastroenterol"},{"key":"5641_CR6","first-page":"606","volume":"21","author":"B Savita","year":"2024","unstructured":"Savita B, Archana B, Aparajita S, Meenakshi V (2024) Decoding Glycobiomarkers in Non-Alcoholic Steatohepatitis (NASH) and Related Hepatocellular Carcinoma (HCC). Curr Proteom 21:606\u2013625","journal-title":"Curr Proteom"},{"key":"5641_CR7","doi-asserted-by":"publisher","first-page":"e18761429259143","DOI":"10.2174\/0118761429259143230927110556","volume":"17","author":"Y Xu","year":"2024","unstructured":"Xu Y, An Z, Wang S, Ni Y, Zhou M, Feng Q et al (2024) Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease. Curr Mol Pharmacol 17:e18761429259143","journal-title":"Curr Mol Pharmacol"},{"key":"5641_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2174\/0109298665301698240404061300","volume":"31","author":"M Sotoudeheian","year":"2024","unstructured":"Sotoudeheian M (2024) Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease. Protein Pept Lett 31:290\u2013304","journal-title":"Protein Pept Lett"},{"key":"5641_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/0113892029313473240919105819","volume":"26","author":"X He","year":"2025","unstructured":"He X, Ma J, Yan X, Yang X, Wang P, Zhang L et al (2025) CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer. Curr Genomics 26:225\u2013243","journal-title":"Curr Genomics"},{"key":"5641_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/0113892029280454240214072212","volume":"25","author":"A Mahmoudi","year":"2024","unstructured":"Mahmoudi A, Hajihasani MM, Majeed M, Jamialahmadi T, Sahebkar A (2024) Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study. Curr Genomics 25:120\u2013139","journal-title":"Curr Genomics"},{"key":"5641_CR11","doi-asserted-by":"publisher","first-page":"1035451","DOI":"10.3389\/fimmu.2022.1035451","volume":"13","author":"N Takamura","year":"2022","unstructured":"Takamura N, Yamaguchi Y (2022) Involvement of caveolin-1 in skin diseases. Front Immunol 13:1035451","journal-title":"Front Immunol"},{"key":"5641_CR12","doi-asserted-by":"publisher","first-page":"768100","DOI":"10.3389\/fphar.2021.768100","volume":"12","author":"S Luo","year":"2021","unstructured":"Luo S, Yang M, Zhao H, Han Y, Jiang N, Yang J et al (2021) Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease. Front Pharmacol 12:768100","journal-title":"Front Pharmacol"},{"key":"5641_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-020-09895-6","volume":"39","author":"P Bernatchez","year":"2020","unstructured":"Bernatchez P (2020) Endothelial caveolin and its scaffolding domain in cancer. Cancer Metastasis Rev 39:471\u2013483","journal-title":"Cancer Metastasis Rev"},{"key":"5641_CR14","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/ATVBAHA.120.314291","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ram\u00edrez CM, Aryal B, Madrigal-Matute J, Liu X, Diaz A et al (2020) Cav-1 (Caveolin-1) Deficiency Increases Autophagy in the Endothelium and Attenuates Vascular Inflammation and Atherosclerosis. Arterioscler Thromb Vasc Biol 40:1510\u20131522","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5641_CR15","doi-asserted-by":"publisher","first-page":"2102643","DOI":"10.1183\/13993003.02643-2021","volume":"60","author":"B Liu","year":"2022","unstructured":"Liu B, Peng Y, Yi D, Machireddy N, Dong D, Ramirez K et al (2022) Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension. Eur Respir J 60:2102643","journal-title":"Eur Respir J"},{"key":"5641_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2023.04.009","volume":"204","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang Y, Chen T, Lin Y, Gong J, Xu Q et al (2023) Caveolin-1 depletion attenuates hepatic fibrosis via promoting SQSTM1-mediated PFKL degradation in HSCs. Free Radic Biol Med 204:95\u2013107","journal-title":"Free Radic Biol Med"},{"key":"5641_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41419-025-07887-4","volume":"16","author":"TD Kabir","year":"2025","unstructured":"Kabir TD, Beck S, Stuart LM, Li J, Hou R, Liu P et al (2025) Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma. Cell Death Dis 16:561","journal-title":"Cell Death Dis"},{"key":"5641_CR18","doi-asserted-by":"publisher","first-page":"116594","DOI":"10.1016\/j.bcp.2024.116594","volume":"230","author":"S Wu","year":"2024","unstructured":"Wu S, Guo N, Xu H, Li Y, Sun T, Jiang X et al (2024) Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4\/ROS\/GPX4 pathway. Biochem Pharmacol 230:116594","journal-title":"Biochem Pharmacol"},{"key":"5641_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74","journal-title":"Signal Transduct Target Ther"},{"key":"5641_CR20","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.lddd.2025.100027","volume":"22","author":"Q Ren","year":"2025","unstructured":"Ren Q, Chen K, Wang L (2025) Epigallocatechin gallate impels osteogenic differentiation of human BMSCs by targeting the METTL3\/SATB2\/Wnt\/\u03b2-catenin axis. Lett Drug Des Discov 22:100027","journal-title":"Lett Drug Des Discov"},{"key":"5641_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/0113892029296712240405053201","volume":"25","author":"M Rashid","year":"2024","unstructured":"Rashid M (2024) Ramifications of m6A Modification on ncRNAs in Cancer. Curr Genomics 25:158\u2013170","journal-title":"Curr Genomics"},{"key":"5641_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H (2022) The role of m6A RNA methylation in cancer metabolism. Mol Cancer 21:14","journal-title":"Mol Cancer"},{"key":"5641_CR23","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1038\/s41598-025-90419-z","volume":"15","author":"Q Li","year":"2025","unstructured":"Li Q, Xiang J (2025) METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6A methylation of FAS. Sci Rep 15:6162","journal-title":"Sci Rep"},{"key":"5641_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","volume":"30","author":"Z Peng","year":"2022","unstructured":"Peng Z, Gong Y, Wang X, He W, Wu L, Zhang L et al (2022) METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Mol Ther 30:932\u2013946","journal-title":"Mol Ther"},{"key":"5641_CR25","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1080\/15384101.2021.1988289","volume":"20","author":"A Dom\u00ednguez-Calvo","year":"2021","unstructured":"Dom\u00ednguez-Calvo A, G\u00f6nczy P, Holland AJ, Balestra FR (2021) TRIM37: a critical orchestrator of centrosome function. Cell Cycle 20:2443\u20132451","journal-title":"Cell Cycle"},{"key":"5641_CR26","doi-asserted-by":"publisher","first-page":"e202010180","DOI":"10.1083\/jcb.202010180","volume":"220","author":"F Meitinger","year":"2021","unstructured":"Meitinger F, Kong D, Ohta M, Desai A, Oegema K, Loncarek J (2021) TRIM37 prevents formation of condensate-organized ectopic spindle poles to ensure mitotic fidelity. J Cell Biol 220:e202010180","journal-title":"J Cell Biol"},{"key":"5641_CR27","doi-asserted-by":"publisher","first-page":"eadl2036","DOI":"10.1126\/sciadv.adl2036","volume":"10","author":"Y Qin","year":"2024","unstructured":"Qin Y, Chen L, Zhu W, Song J, Lin J, Li Y et al (2024) TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington\u2019s disease. Sci Adv 10:eadl2036","journal-title":"Sci Adv"},{"key":"5641_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/0113892029331751240820111158","volume":"26","author":"Z Duan","year":"2025","unstructured":"Duan Z, Liang Y, Xiu X, Ma W, Mei H (2025) ResUbiNet: A Novel Deep Learning Architecture for Ubiquitination Site Prediction. Curr Genomics 26:302\u2013311","journal-title":"Curr Genomics"},{"key":"5641_CR29","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.3390\/molecules26216682","volume":"26","author":"S Toma-Fukai","year":"2021","unstructured":"Toma-Fukai S, Shimizu T (2021) Structural Diversity of Ubiquitin E3 Ligase. Molecules 26:6682","journal-title":"Molecules"},{"key":"5641_CR30","doi-asserted-by":"crossref","unstructured":"Gui M, Yao L, Lu B, Li J, Wang J, Zhou X et al (2022) Modified Yuejuwan Inhibited Cholesterol Accumulation and Inflammation in THP-1 Macrophage-Derived Foam Cells by Inhibiting the Activity of the TRIM37\/TRAF2\/NF-\u03baB Pathway. Evid Based Complement Alternat Med 2022:6400517","DOI":"10.1155\/2022\/6400517"},{"key":"5641_CR31","first-page":"53","volume":"10","author":"GH Deng","year":"2023","unstructured":"Deng GH, Wu CF, Li YJ, Shi H, Zhong WC, Hong MK et al (2023) Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease. Mil Med Res 10:53","journal-title":"Mil Med Res"},{"key":"5641_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.molimm.2023.09.003","volume":"163","author":"T You","year":"2023","unstructured":"You T, Li Y, Li B, Wu S, Jiang X, Fu D et al (2023) Caveolin-1 protects against liver damage exacerbated by acetaminophen in non-alcoholic fatty liver disease by inhibiting the ERK\/HIF-1\u03b1 pathway. Mol Immunol 163:104\u2013115","journal-title":"Mol Immunol"},{"key":"5641_CR33","doi-asserted-by":"publisher","first-page":"109558","DOI":"10.1016\/j.intimp.2022.109558","volume":"114","author":"X Jiang","year":"2023","unstructured":"Jiang X, Li Y, Fu D, You T, Wu S, Xin J et al (2023) Caveolin-1 ameliorates acetaminophen-aggravated inflammatory damage and lipid deposition in non-alcoholic fatty liver disease via the ROS\/TXNIP\/NLRP3 pathway. Int Immunopharmacol 114:109558","journal-title":"Int Immunopharmacol"},{"key":"5641_CR34","doi-asserted-by":"publisher","first-page":"717276","DOI":"10.3389\/fphar.2021.717276","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Jiang W, Xin J, Xue W, Shi C, Wen J et al (2021) Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway. Front Pharmacol 12:717276","journal-title":"Front Pharmacol"},{"key":"5641_CR35","doi-asserted-by":"publisher","first-page":"217191","DOI":"10.1016\/j.canlet.2024.217191","volume":"604","author":"H Han","year":"2024","unstructured":"Han H, Yuan Y, Li C, Liu L, Yu H, Han G et al (2024) RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Lett 604:217191","journal-title":"Cancer Lett"},{"key":"5641_CR36","doi-asserted-by":"publisher","first-page":"e09477","DOI":"10.1002\/advs.202509477","volume":"12","author":"H Han","year":"2025","unstructured":"Han H, Wang S, Ma L, Yin H, Cheng X, Wang Y et al (2025) ASH2L-K312-Lac Stimulates Angiogenesis in Tumors to Expedite the Malignant Progression of Hepatocellular Carcinoma. Adv Sci (Weinh) 12:e09477","journal-title":"Adv Sci (Weinh)"},{"key":"5641_CR37","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41388-025-03550-6","volume":"44","author":"H Han","year":"2025","unstructured":"Han H, Gong C, Zhang Y, Liu C, Wang Y, Zhao D et al (2025) RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma. Oncogene 44:3955\u20133973","journal-title":"Oncogene"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05641-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05641-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05641-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:15:11Z","timestamp":1787908511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05641-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5641"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05641-8","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical aspects of this research were authorized by the Animal Care and Use Committee of the Second Qilu Hospital of Shandong University (KYLL202604651), The animal study strictly followed the ARRIVE guidelines and the 3Rs principle (Replacement, Reduction, Refinement). The study was approved by the Ethics Committee of the Second Qilu Hospital of Shandong University and complied with the Declaration of Helsinki. Written informed consent was obtained from each subject.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}